PREVDUO .2 mg/mL
neostigmine methylsulfate and glycopyrrolate · INJECTION · Endo USA
PREVDUO is a injection containing neostigmine methylsulfate and glycopyrrolate at .2 mg/mL, taken intravenous. Manufactured by Endo USA.
Key Facts
- Brand Name
- PREVDUO
- Generic Name
- neostigmine methylsulfate and glycopyrrolate
- NDC Code (Product)
42023-269- Manufacturer
- Endo USA
- Strength
- .2 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA216903
- Marketing Start
- 05/15/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is PREVDUO used for?
PREVDUO contains neostigmine methylsulfate and glycopyrrolate. It is a injection taken intravenous. Consult your doctor for specific uses.
Is PREVDUO a controlled substance?
PREVDUO is not classified as a controlled substance by the DEA.
What is the generic name for PREVDUO?
The generic name for PREVDUO is neostigmine methylsulfate and glycopyrrolate. There are no other listed brand versions of neostigmine methylsulfate and glycopyrrolate.
What is the NDC code for PREVDUO .2 mg/mL?
The NDC (National Drug Code) for PREVDUO .2 mg/mL is 42023-269, listed by Endo USA.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)